(Q43184260)

15 November 2017

Effects of combination treatment with alendronate and vitamin K(2) on bone mineral density and strength in ovariectomized mice (English)

1 reference

15 November 2017

0 references

1 reference

Hiroshi Sasaki

1

1 reference

15 November 2017

Naohisa Miyakoshi

2

1 reference

15 November 2017

Yuji Kasukawa

3

1 reference

15 November 2017

Shigeto Maekawa

4

1 reference

15 November 2017

Hideaki Noguchi

5

1 reference

15 November 2017

Keji Kamo

6

1 reference

15 November 2017

Yoichi Shimada

7

1 reference

15 November 2017

26 January 2010

1 reference

Journal of Bone and Mineral Metabolism

15 November 2017

1 reference

15 November 2017

28

1 reference

15 November 2017

4

1 reference

15 November 2017

403-409

1 reference

https://scigraph.springernature.com/pub.10.1007/s00774-009-0148-5

15 November 2017

0 references

cites work

Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00774-009-0148-5

Effects of vitamin K2 (menatetrenone) and alendronate on bone mineral density and bone strength in rats fed a low-magnesium diet

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00774-009-0148-5

Long-term risedronate treatment normalizes mineralization and continues to preserve trabecular architecture: sequential triple biopsy studies with micro-computed tomography

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00774-009-0148-5

Bone material properties in trabecular bone from human iliac crest biopsies after 3- and 5-year treatment with risedronate

21 January 2018

1 reference

12 December 2020

Vitamin K2 regulation of bone homeostasis is mediated by the steroid and xenobiotic receptor SXR.

1 reference

12 December 2020

Lack of insulin-like growth factor I exaggerates the effect of calcium deficiency on bone accretion in mice

1 reference

12 December 2020

Effects of vitamin K2 on the development of osteopenia in rats as the models of osteoporosis

1 reference

12 December 2020

Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib.

1 reference

12 December 2020

Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women

1 reference

12 December 2020

Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials

1 reference

12 December 2020

Alendronate distributed on bone surfaces inhibits osteoclastic bone resorption in vitro and in experimental hypercalcemia models

1 reference

12 December 2020

Drug-induced prevention of gastrectomy- and ovariectomy-induced osteopaenia in the young female rat.

1 reference

12 December 2020

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

1 reference

12 December 2020

Alendronate for the Treatment of Osteoporosis in Men

1 reference

12 December 2020

Alendronate reduces adhesion of human osteoclast-like cells to bone and bone protein-coated surfaces

1 reference

12 December 2020

Effect of vitamin K2 on three-dimensional trabecular microarchitecture in ovariectomized rats

1 reference

12 December 2020

Additive effect of vitamin K2 and risedronate on long bone mass in hypophysectomized young rats

1 reference

12 December 2020

Bisphosphonate treatment suppresses not only stochastic remodeling but also the targeted repair of microdamage

1 reference

12 December 2020

Combination use of vitamin K(2) further increases bone volume and ameliorates extremely low turnover bone induced by bisphosphonate therapy in tail-suspension rats

1 reference

12 December 2020

Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women

1 reference

12 December 2020

Comparative efficacy of hormone replacement therapy, etidronate, calcitonin, alfacalcidol, and vitamin K in postmenopausal women with osteoporosis: The Yamaguchi Osteoporosis Prevention Study

1 reference

12 December 2020

Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women. Phase III Osteoporosis Treatment Study Group

1 reference

12 December 2020

Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis

1 reference

12 December 2020

Infrared analysis of bones in magnesium-deficient rats treated with vitamin K2

1 reference

12 December 2020

Vitamin K2 promotes 1alpha,25(OH)2 vitamin D3-induced mineralization in human periosteal osteoblasts

1 reference

12 December 2020

Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group

1 reference

12 December 2020

Severely suppressed bone turnover: a potential complication of alendronate therapy

1 reference

12 December 2020

Osteoporosis prevention, diagnosis, and therapy

1 reference

12 December 2020

10.1007/S00774-009-0148-5

Identifiers

DOI

1 reference

Dimensions Publication ID

15 November 2017

0 references

1 reference